The extracellular matrix (ECM) is the natural material niche of the human body. By coordinating a complex array of biochemical and biophysical cues, the ECM plays an important role in both normal physiological processes and disease. However, nearly all commercially available cell culture platforms or scaffolds are static, which can lead to a mismatch between in vitro experiments and in vivo behavior. To further our understanding of in vivo processes, we are developing new materials that can mimic the dynamic properties of real tissues. Our current focus is to engineer well-defined polymeric hydrogels with precise temporal control over bulk and local mechanics using stimuli-responsive and dynamic chemistries. Broadly, we apply our materials toward understanding disease mechanisms, advanced tissue engineering scaffolds, and cell expansion and delivery vehicles. 

TM FitzSimons, F Oentoro, TV Shanbhag, EV Anslyn, AM Rosales. "Preferential Control of Forward Reaction Kinetics in Hydrogels Crosslinked with Reversible Conjugate Additions," Macromolecules, (2020).

AJ Graham, CM Dundas, A Hillsley, DS Kasprak, AM Rosales, BK Keitz. "Genetic control of radical crosslinking in a semi-synthetic hydrogel," ACS Biomaterials Science and Engineering, (2020).

Biological polymers such as proteins are responsible for nearly every facet of life and contain exquisite properties ranging from structural (e.g., spider silk) to signal transduction (e.g., insulin). Both monomer sequence and chain shape dictate protein function, but such sequence control is difficult to replicate with conventional synthetic polymers. Our work probes the relationship between sequence and structure using a simplified class of biomimetic materials, polypeptoids, and we leverage this molecular control to develop synthetic materials with enhanced bioactivity. Because polypeptoids are non-natural, they provide opportunities to interface with biologics in an orthogonal manner and to generate materials with precise control.